The Patent Finder

Neoantigen Identification, Manufacture, and Use

Gritstone Bio, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 15/466,729, filed Mar 22, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,055,540Neoantigen Identification, Manufacture, and Use
In force
 · High confidence
UsedRemaining
Seattle Project Corp.In forceHigh confidence
US 10,847,252Neoantigen Identification, Manufacture, and Use
In force
 · High confidence
Gritstone Bio, Inc.In forceHigh confidence
US 10,847,253Neoantigen identification, manufacture, and use
In force
 · High confidence
Gritstone Bio, Inc.In forceHigh confidence
US 11,183,286Neoantigen Identification, Manufacture, and Use
In force
 · High confidence
Gritstone Bio, Inc.In forceHigh confidence
Application 15/381,375Neoantigen Identification, Manufacture, and Use
Abandoned
Abandoned Jan 18, 2021
Seattle Project Corp.AbandonedAbandoned Jan 18, 2021
Application 17/101,522Neoantigen Identification, Manufacture, and Use
Abandoned
Abandoned Mar 24, 2026
Seattle Project Corp.AbandonedAbandoned Mar 24, 2026
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Gritstone Bio, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited